The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial

På svenska

Author

  • Ulf-Henrik Mellqvist
  • Jan Westin
  • Peter Gimsing
  • Oyvind Hjertner
  • Stig Lenhoff
  • Edward Laane
  • Kari Remes
  • Hlif Steingrimsdottir
  • Niels Abildgaard
  • Lucia Ahlberg
  • Kristina Carlsson
  • Inge Marie Dahl
  • Karin Forsberg
  • Tobias Gedde-Dahl
  • Henrik Gregersen
  • Astrid Gruber
  • Nina Guldbrandsen
  • Einar Haukas
  • Olle Linder
  • Hareth Nahi
  • Ingerid Nesthus
  • Nilsaage Toffner-Clausen
  • Raija Silvennoinen
  • Niels Frost Andersen
  • Ingemar Turesson
  • Anders Waage
Show all

Publishing year

2009

Language

English

Pages

221-221

Publication/Series

Blood

Volume

114

Issue

22

Document type

Conference paper: abstract

Publisher

American Society of Hematology

Topic

  • Hematology

Conference name

51st Annual Meeting of the American-Society-of-Hematology

Conference date

2009-12-05 - 2009-12-08

Status

Published

ISBN/ISSN/Other

  • ISSN: 1528-0020